Matthew S. Corbett

Design of Selective, ATP-Competitive Inhibitors of Akt

Kevin D. Freeman‐Cook, Christopher Autry, Gary Borzillo et al. · Journal of Medicinal Chemistry · 2010 · 75 citations · Full text

Pharmaceutical Science, Bioorganic Chemistry, Pharmacotherapy +16

Synthesis and structure based optimization of novel Akt inhibitors

Blaise Lippa, Gonghua Pan, Matthew S. Corbett et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 74 citations · Full text

Medicinal Chemistry, Medicine, Rational Drug Design +5

Discovery of Allosteric, Potent, Subtype Selective, and Peripherally Restricted TrkA Kinase Inhibitors

Sharan K. Bagal, Kiyoyuki Omoto, David C. Blakemore et al. · Journal of Medicinal Chemistry · 2018 · 52 citations · Full text

Drug Target, Immunology, Molecular Pain +17

Discovery of novel isothiazole inhibitors of the TrkA kinase: Structure–activity relationship, computer modeling, optimization, and identification of highly potent antagonists

Blaise Lippa, Joel Morris, Matthew S. Corbett et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 47 citations · Full text

Medicinal Chemistry, Drug Target, Novel Isothiazole Inhibitors +10

Cycloadditions of chiral anthracenes: effect of the trifluoromethyl group

Matthew S. Corbett, Xiang Liu, Amitav Sanyal et al. · Tetrahedron Letters · 2003 · 37 citations

Organic Chemistry, Chiral Anthracenes, Heterocyclic +1